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Pulmonary prophylactic impact of melatonin and/or quercetin: 
A novel therapy for inflammatory hypoxic stress in rats
The study aims to compare, through histological and bio-
chemical studies, the effects of quercetin, melatonin and 
their combination in regulation of immuno-inflammatory 
mediators and heat shock protein expressions in sodium 
nitrite induced hypoxia in rat lungs. The results revealed 
that NaNO2 injection caused a significant decrease in Hb 
in rats, while serum levels of TNF-a, IL-6 and CRP, VEGF 
and HSP70 were elevated compared to the control group. 
Administration of melatonin, quercetin or their combina-
tion before NaNO2 injection markedly reduced these pa-
rameters. Histopathological examination of the lung tis-
sue supported these biochemical findings. The study 
suggests that melatonin and/or quercetin are responsible 
for lung tissue protection in hypoxia by downregulation 
of immuno-inflammatory mediators and heat shock pro-
tein expressions. Pre-treatment of hypoxic animals with a 
combination of melatonin and quercetin was effective in 
modulating most of the studied parameters to near-nor-
mal levels.
Keywords: hypoxia, melatonin, quercetin, inflammatory 
mediators, heat shock protein
Exposure to hypoxia favors the increase of reactive oxygen species and modifies the 
levels of antioxidant substances, causing pulmonary oxidative damage, as well as estab-
lishing an inflammatory process (1). Imbalance of the redox state in lungs induced by 
hypoxia has been suggested to be a participant in the changes observed in lung function 
(1, 2). Hypoxia has an important role in triggering the vascular endothelial growth factor 
(VEGF), which is a signal protein produced by alveolar macrophages and other cell 
types. This factor stimulates vasculogenesis and angiogenesis to restore oxygen supply 
to tissues during hypoxia (3). However, VEGF has a deleterious role in pulmonary ede-
ma formation by increasing vascular permeability during hypoxia (4).
Oxygen homeostasis is maintained through a family of hypoxia-inducible transcrip-
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subunit (HIF-1a and HIF-2a) that is tightly regulated by tissue oxygen levels (4). Abnormal 
activation or deregulation of hypoxia-induced transcriptional pathways may contribute to 
the pathogenesis of various conditions. Hypoxia, via the transcription factor, hypoxia-in-
ducible factor HIF-1a, induces a large number of genes encoding proteins, which partici-
pate in inflammation (5). A cross-talk between hypoxic and non-hypoxic signaling path-
ways, including pro-inflammatory cytokines, such as tumor necrosis factor-a and 
interleukin-1b, may further amplify inflammatory responses by activating HIF as well as 
other oxygen-sensitive transcription factors, for example, nuclear factor-kB (NF-kB) (6). 
Expression of heat shock proteins (HSPs) is another mechanism involved in inflammatory 
reactions during hypoxia. Heat shock proteins (HSPs) are a group of stress intracellular 
proteins whose expression increases in response to hypoxic stress which function as cyto-
protectants by inhibiting various inflammatory mediators (7). However, cell damage may 
evoke an early release of these proteins outside the cell (8). Extracellular HSP acts as a 
danger signal to innate immunity and can be recognized by antigen presenting cells (APC) 
and their interaction subsequently triggers APC to produce the proinflammatory cyto-
kines and activate the nuclear factor (NF)-kB, thus initiating the adaptive immune re-
sponse and the presentation of antigens to the cytotoxic T cells (9). Thus, agents with the 
ability to suppress the expression of inflammatory molecules may be beneficial in reduc-
ing the risk of tissue injury and organ dysfunction during hypoxia.
Melatonin (N-acetyl-5-methoxytryptamine), which is secreted in the circulation from 
the pineal gland, is produced in small amounts in the retina, the gastrointestinal system and 
by leukocytes. It has protective effects against cellular injuries through its potent antioxidant 
and anti-inflammatory properties at both physiological and pharmacological concentrations 
(10). Melatonin possesses anti-angiogenic activity by inhibiting stabilization of HIF-1a in 
HCT 116 cell lines (11). Also, it has been shown that melatonin could invert the upregulation 
in HSP70 gene expression in human epidermis exposed to ultraviolet radiation (12).
Quercetin is a flavonoid present in many vegetables, fruits, and beverages; it pos-
sesses a broad range of pharmacological properties, including anti-inflammatory, anti-
proliferative and anti-oxidative (13). A previous study demonstrated that quercetin can 
elicit protective effects in different lung injury models (14, 31). At the molecular level, quer-
cetin inhibits pulmonary oxidant stress in lung epithelial cells through inducing heme 
oxygenase-1 (HO-1) and via modulating the expression of antioxidant genes (14).
Although both melatonin and quercetin show different pharmacological mechanisms 
in modulating several pathological conditions, their modulating mechanisms for the ex-
pression of different types of inflammatory proteins causing lung tissue damage during 
hypoxia, particularly when used in combination, are still unclear. The present study aims 
to explore the effects of quercetin, melatonin or their combination in regulation of inflam-
matory protein expressions including VEGF, immuno-inflammatory mediators and HSP70 
in hypoxic lung induced by sodium nitrite in rats.
EXPERIMENTAL
Chemicals
All chemicals used in the study were of high analytical grade, products of Sigma-Al-
drich (USA) and Merck (Germany).
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Animals and treatments
Fifty adult male Wistar albino rats weighing 170–200 g were used in the study. Rats 
were obtained from the Experimental Animal House, Faculty of Pharmacy, King Saud Uni-
versity, Saudi Arabia. Animals were housed in special clean cages and maintained under 
standard conditions (12-h light/dark cycle, temperature 20–22 °C and 60 % humidity). For 
acclimatization, rats were fed the standard rat pellet chow with free access to tap water ad 
libitum for one week before the experiment. The animal experimental protocol was approved 
by the Experimental Animal Ethics Committee of the King Saud University, Faculty of Phar-
macy (Riyadh, Saudi Arabia). After one week of acclimatization, the rats were randomly 
divided into five groups of ten rats each. Group 1 served as the control, group 2 – NaNO2-
treated animals, group 3 – NaNO2-treated animals injected with melatonin (200 mg kg–1, i.p.), 
group 4 – NaNO2-treated animals injected with quercetin (200 mg kg–1, i.p.), group 5 – Na-
NO2-treated animals injected with a combination of melatonin (200 mg kg–1, i.p.) and quer-
cetin (200 mg kg–1, i.p.). NaNO2 (60 mg kg–1) was administered as a single dose subcutane-
ously. Melatonin and quercetin were administered 24 hours before NaNO2 injection. One 
hour after NaNO2 injection, the rats were sacrificed under ether anesthesia; blood samples 
were collected and divided into two parts. One part was collected into tubes containing 
heparin for hemoglobin determination. The other part was allowed to coagulate and was 
centrifuged for serum separation and used for serum biochemical analysis. After blood col-
lection, the lungs were removed and placed in phosphate-buffered 10 % formalin overnight 
for fixation and histopathological examination.
Determination of Hb
Hb was determined colorimetrically using Drabkin’s reagent according to the method 
after Kjeldsberg (15).
Biochemical serum analyses
Interleukin-6 (IL-6) was measured using a highly sensitive rat enzyme-linked immu-
nosorbent assay (ELISA) kit (IBL International GmbH, Germany) following the manufac-
turer’s instructions. Tumor necrosis factor-a (TNF-a) was measured using the ELISA assay 
kit following instructions supplied by the manufacturer (DuoSet kits, R&D Systems, USA). 
C-reactive protein (CRP) was estimated using the immunonephelometric assay (Dade Beh-
ring N Latex High Sensitivity CRPTM mono assay) on a Behring Nephelometer II ana-
lyzer (Dade Behring Diagnostics Inc., USA). The level of VEGF was assayed by colorimet-
ric, quantitative, sandwich ELISA (R&D Systems, UK) at 492 nm, following the 
manufacturer’s instructions. A sandwich rat HSP70 ELISA kit was used for quantitative 
determination of HSP70 (Kamiya Biomedical, USA).
Histopathological examination
Small pieces of the lung were fixed in 10 % buffered formalin at 4 °C for 24 hours and 
processed to prepare 5-µm thick paraffin sections. These sections were stained with he-
matoxylin and eosin (H&E) to detect pathological changes due to hypoxia and the effect of 
certain drugs on these changes.
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Statistical analysis
Data were analyzed by comparing the values for different treatment groups with the 
values of individual controls. Results were expressed as mean ± SD. Significant differences 
among the values were analyzed using the one-way analysis of variance (ANOVA) fol-
lowed by Bonferroni’s test post-ANOVA.
RESULTS AND DISCUSSION
Fig. 1 shows the effect of melatonin and/or quercetin on blood Hb concentration in the 
control and NaNO2-induced hypoxia in experimental groups. In line with previous studies 
(16), the present work demonstrated that induction of hypoxia in rats by NaNO2 caused a 
decrease in blood Hb level (57.9 %) compared to normal animals (p ≤ 0.001). This result may 
indicate the development of anemia in rats in response to hypoxia. The decrease in Hb 
level may be attributed to a decrease in the red blood cell count in response to NaNO2. A 
previous preliminary study reported a significantly reduced red blood cell count in rats 
exposed to NaNO2 toxicity (13). Nitrite in toxic doses has been reported to induce hemic 
hypoxia. The underlying mechanism of such effect is mainly due to increased methemoglo-
bin formation (17). Some authors have reported that NaNO2 can induce oxidative damage 
through free radical generation, which stimulates the oxidation of ferrous ions in oxyhemo-
globin to form methemoglobin and erythrocyte lysis (18). We have found that administra-
tion of melatonin and/or quercetin to hypoxic rats significantly ameliorated the reduced 
level of blood Hb compared to hypoxic untreated animals (p ≤ 0.001). In comparison with 
the control, the changes were 23.6, 14.3 and 13.2 %, respectively. RBCs are highly exposed to 
oxygen and can be a site for radical formation under pathological conditions, resulting in 
their destruction. In this study, the administration of melatonin alone showed significant 
Fig. 1. Effect of melatonin (Mel) and/or quercetin (Qr) on blood hemoglobin (Hb) in the control and 
hypoxia treated groups. Data are expressed as mean ± SD (n = 10). Significant difference compared to 
the control group: a p  ≤ 0.001, b p  ≤ 0.01, c p  ≤ 0.05; compared to the hypoxia group:*p  ≤ 0.001, compared 
to the combination group (hypoxia + Mel + Qr): $p  ≤ 0.05, using ANOVA, followed by Bonferroni as a 
post-ANOVA test.
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improvement in the Hb levels compared to hypoxic untreated rats (p ≤ 0.001), which is in 
agreement with a previous study that reported that melatonin leads to a significant increase 
in the hemoglobin level and erythrocyte count in healthy humans (19). Melatonin is ac-
tively taken up into erythrocytes under oxidative stress and is consumed in the defense of 
the cell, delaying Hb denaturation and release of hemin (20). Also, the protective effect of 
quercetin may rely on its antioxidant and anti-inflammatory properties. A previous study 
reported that quercetin could prevent the decrease in nuclear translocation of Nrf2, a key 
regulator of the antioxidant response, and the increase in reactive oxygen species levels by 
inhibiting enhancement of NADPH oxidase and xanthine oxidase activities (21).
Among the genes regulated via the HIF-1a pathway under hypoxic conditions are the 
highly conserved HSPs, which act as cellular chaperones for proteins misfolded by cellular 
stress (22). In this study, HSP70 was significantly higher in the hypoxia induced group 
compared to the control (Fig. 2, p ≤ 0.001) with a percentage change of 83.1 %. This finding 
was in agreement with the recent study of Tsuchida et al. (23), who suggested that under 
hypoxia the HIF-1a-induced HSP70 overexpression in chondrocytes enhanced the meta-
bolic activity of chondrocytes and chondroprotective effects.
Administration of melatonin and/or quercetin before NaNO2 injection markedly re-
duced the dramatic increase in HSP70 levels compared to NaNO2 untreated animals (p ≤ 
0.001). Percentage changes from normal were 20.8, 22.6 and 9.4 %, respectively. Pretreat-
ment of NaNO2 hypoxic animals with the combination of melatonin and quercetin was 
more effective in modulating most of the studied parameters to near-normal levels than 
each agent individually. Moreover, it has been reported that melatonin effectively pre-
vented acidification of cytosol, causing significant downregulation of HSP70 in melatonin-
incubated skin samples (24).
In line with the previous study (3), the vascular endothelial growth factor (VEGF) was 
significantly increased after hypoxia (32.9 % change from normal) and administration of 
melatonin and/or quercetin ameliorated the hypoxic effect (Fig. 3, p ≤ 0.001) by 8.3, 8.3 and 
6.9 % from normal, respectively. This may be due to the activation of HIF-1 in hypoxia, 
Fig. 2. Effect of melatonin (Mel) and/or quercetin (Qr) on serum VEGF in the control and hypoxia 
treated groups. Data are expressed as mean ± SD (n = 10). Significant difference compared to the con-
trol group: a p  ≤  0.001, c p  ≤  0.05; compared to the hypoxia group: * p  ≤  0.001; compared to the com-
bination group (hypoxia + Mel + Qr): $ p  ≤  0.05, using ANOVA, followed by Bonferroni as a post-
ANOVA test.
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resulting in increased expression of a number of genes encoding proteins such as erythro-
poietin (EPO), vascular endothelial growth factor (VEGF) and inducible nitric oxide syn-
thase (iNOS), which increase tissue oxygenation. These factors allow adaptation to hy-
poxia, which is directed toward increasing tissue perfusion and oxygenation and hence 
overcoming the initial hypoxic insult. Melatonin suppressed HIF-1a transcriptional activity, 
leading to reduction in different angiogenic processes such as VEGF expression (20).
In the present study, quercetin inhibited hypoxia-induced VEGF, which was in accord 
with the study of Anso et al. (25). When cells were exposed to hypoxia in the presence of 
this flavonoid, HIF-1a translocated to the nucleus and interacted with p300/CBP, but this 
complex was transcriptionally inactive. Taken together, these findings indicate that flavo-
noids impair VEGF transcription by an alternative mechanism that does not depend on 
nuclear HIF levels (26).
Furthermore, the current study revealed that rats exposed to hypoxia exhibited higher 
circulating levels of TNF-a, IL-6 and CRP compared to the controls (Figs. 3, 4 and 5, 
resp., p ≤ 0.001). Deviations in the levels of these inflammatory markers from the normal 
level were 74.0, 57.4 and 100.0 %, respectively. These results have shown that the release of 
pro-inflammatory cytokines, which are the systemic inflammatory markers, is associated 
with hypoxia (6). Parts of our findings are consistent with other reports of increased TNF-
a and IL-6 levels in rats subjected to hypoxia (6). When exposed to hypoxia, NF-kB is acti-
vated and stimulates increased production of circulating cytokines such as TNF-a and 
IL-6, which, in turn, activates signaling cascades to enhance NF-kB activation. Positive 
regulation contributes to the amplification of inflammatory responses (6).
Pre-injection of the studied agents, alone or in combination, to rats before induction 
of hypoxia, successfully attenuated hypoxia-induced stimulation of the inflammatory im-
munologic biomarkers, TNF-a, IL-6 and CRP. This beneficial impact of the two agents may 
be related to their beneficial anti-inflammatory and immunomodulatory actions. This re-
sult is confirmed by previous investigations, reporting that supplementation of either 
quercetin or melatonin could protect against the inflammatory responses caused by dif-
Fig. 3. Effect of melatonin (Mel) and/or quercetin (Qr) on serum HSP70 in the control and hypoxia 
treated groups. Data are expressed as mean ± SD (n = 10). Significant difference compared to the con-
trol group: a p  ≤  0.001, b p  ≤  0.01, c p  ≤  0.05; compared to the hypoxia group: * p  ≤  0.001; compared to 
the combination group (hypoxia + Mel + Qr): $ p  ≤  0.05, using ANOVA, followed by Bonferroni as a 
post-ANOVA test.
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ferent pathological conditions through inhibition of the expression of these mediators (4, 
13). Indeed, our results show that administration of melatonin significantly decreased the 
amount of inflammatory cytokines TNF-a and IL-6 of the hypoxic rats (p ≤ 0.001). Melato-
nin modulates inflammation by inhibiting the NF-kB nuclear erythroid 2-related factor 2 
(Nrf2) cascades and downstream mediators of inflammation (27). Quercetin exerts its an-
tioxidant properties by scavenging reactive oxygen and nitrogen species. It increases en-
dothelial nitric oxide and induces vasodilatation through smooth muscle relaxation. It has 
been experimentally used in the treatment of ischemia and myocarditis (28). Experimental 
studies have reported that quercetin protects from ischemia-reperfusion injury through 
prevention of apoptosis and inhibition of the mitochondria-dependent caspase pathway 
in animals (29).
Fig. 4. Effect of melatonin (Mel) and/or quercetin (Qr) on serum TNF-α in the control and hypoxia 
treated groups. Data are expressed as mean ± SD (n = 10). Significant difference compared to the con-
trol group: a p  ≤  0.001, c p  ≤  0.05; compared to the hypoxia group: * p  ≤  0.001; compared to the com-
bination group (hypoxia + Mel + Qr): $ p  ≤  0.05, using ANOVA, followed by Bonferroni as a post-
ANOVA test.
Fig. 5. Effect of melatonin (Mel) and/or quercetin (Qr) on serum IL-6 in the control and hypoxia 
treated groups. Data are expressed as mean ± SD (n = 10). Significant difference compared to the con-
trol group: a p  ≤  0.001, b p  ≤  0.01, c p  ≤  0.05; compared to the hypoxia group: * p  ≤  0.001, using ANO-
VA, followed by Bonferroni as a post-ANOVA test.
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Fig. 6. Effect of melatonin (Mel) and/or quercetin (Qr) on serum CRP in the control and hypoxia treated 
groups. Data are expressed as mean ± SD (n = 10). Significant difference compared to the control group: 
a p  ≤  0.001, c p  ≤  0.05; compared to the hypoxia group: * p  ≤  0.001; compared to the combination group 
(hypoxia + Mel + Qr): $ p  ≤  0.05, using ANOVA, followed by Bonferroni as a post-ANOVA test.
Fig. 7. Light photomicrographs of rat lung stained with hematoxylin and eosin (scale bar: 100 µm), 
representing: a) normal lung alveoli and septae (arrow), b) section of lung from a rat exposed to hy-
poxia showing marked thickening of interalveolar septa (arrow) and alveoli and foci of inflamma-
tory cellular infiltration (star), c)–e) sections of lung from a rat exposed to hypoxia receiving melato-
nin, quercetin and a combination of both, respectively.
a)                                                                              b)
c)                                                                              d)
                                          e)
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Extensive variations were observed during the histopathological study of rat lungs. 
Administration of NaNO2 caused degeneration of the alveoli and thickening of interalveo-
lar septae in addition to focal cellular infiltration (Figs. 7a-e). Similar observation was 
found in another study during CCl4 administration to rat lungs (30). Treatment with mela-
tonin or quercetin showed marked improvement of the alveoli and alveolar septae and a 
marked decrease of cellular infiltration, especially in rats that received a combination of 
melatonin and quercetin. This beneficial effect of both melatonin and quercetin was previ-
ously documented in animals that underwent experimental lung damage (31). Greater 
improvement of pathological changes is obvious in rats that received co-treatment of both 
drugs. This result may predict the beneficial synergistic protective impact of the combina-
tion of melatonin and quercetin against lung damage induced by hypoxia.
CONCLUSIONS
The obtained results have proven that melatonin and/or quercetin are likely to be re-
sponsible for lung tissue protection against hypoxic lung damage in rats through their 
downregulation of immuno-inflammatory mediators and heat shock protein expressions. 
The combination of melatonin and quercetin was more effective in modulating most of the 
studied parameters to near-normal levels than each agent individually. Therefore, the cur-
rent findings may have important implications on the development of a new therapeutic 
strategy aimed at manipulating melatonin and quercetin in combination as a supplement 
for prophylaxis from hypoxic lung injury.
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